NecroIr2, an iridium(III) complex, functions as a necroptosis inducer in cisplatin-resistant lung cancer cells (A549R). It preferentially accumulates in mitochondria, causing oxidative stress and a reduction in mitochondrial membrane potential (MMP). Moreover, NecroIr2 initiates the activation of receptor-interacting serine/threonine kinase 3 (RIPK3) and mixed lineage kinase domain-like pseudokinase (MLKL), while also regulating CDK4 expression [1].
Molecular Weight:
926.44
Formula:
C46H30ClIrN6O2-
Target:
RIP kinase|||CDK|||Others|||MLK
* VAT and and shipping costs not included. Errors and price changes excepted
